NCT03384758

Brief Summary

Aim of this prospective clinical study is the Evaluation of the Effect of Compression Therapy on the Microcirculation in Patients With Leg Edema and Mild to Moderate PAD or Diabetes Mellitus.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 27, 2017

Completed
4 months until next milestone

Study Start

First participant enrolled

May 1, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2019

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2019

Completed
Last Updated

May 8, 2020

Status Verified

May 1, 2020

Enrollment Period

9 months

First QC Date

December 12, 2017

Last Update Submit

May 6, 2020

Conditions

Keywords

Compression therapyMicrocirculationDiabetes mellitusPeripheral Arterial Disease

Outcome Measures

Primary Outcomes (4)

  • Number of participants with treatment-related adverse events as assessed by questionnaire

    The Adverse Events are defined in the questionnaire as: Abort of the Therapy, Pressure marks, Quantification of the wearing comfort (Points 1-10), subjective reduction of the leg edema (Points 1-10)

    12 Months

  • sO2

    The Perfusion Situation should be recorded on the Level of Microcirculation by the Parameter sO2

    12 Months

  • Flow

    The Perfusion Situation should be recorded on the Level of Microcirculation by the Parameter Flow

    12 Months

  • rHb

    The Perfusion Situation should be recorded on the Level of Microcirculation by the Parameter rHb

    12 Months

Study Arms (3)

mild to moderate PAD

ACTIVE COMPARATOR
Device: Compression Therapy

Diabetes mellitus

ACTIVE COMPARATOR
Device: Compression Therapy

Healthy volunteers

PLACEBO COMPARATOR
Device: Compression Therapy

Interventions

Therapy of the leg edema with compression stockings class I for three hours, after a short break with compression stocking class II for again three hours.

Diabetes mellitusHealthy volunteersmild to moderate PAD

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Study-Arm PAD:
  • leg edema
  • symptomatic PAD (Fontaine stage II)
  • no palpable foot pulses
  • ABI \<0.9 and \>0.6, absolute ankle pressure \> 60mmHg
  • Study-Arm Diabetes:
  • leg edema
  • Diabetes mellitus Typ 2 (history of longer than 2 years)
  • palpable foot pulses
  • Pallaesthesie \>6
  • Wagner Score 0

You may not qualify if:

  • Study-Arm PAD:
  • Critical limb ischemia
  • ABI \< 0.6
  • simoultaneous Diabetes Mellitus
  • Study-Arm Diabetes:
  • Wagner Score \>0
  • Pallasthesie \<6

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Erlangen, Vascular Surgery

Erlangen, 91054, Germany

Location

Related Publications (1)

  • Rother U, Grussler A, Griesbach C, Almasi-Sperling V, Lang W, Meyer A. Safety of medical compression stockings in patients with diabetes mellitus or peripheral arterial disease. BMJ Open Diabetes Res Care. 2020 Jun;8(1):e001316. doi: 10.1136/bmjdrc-2020-001316.

MeSH Terms

Conditions

Peripheral Arterial DiseaseDiabetes Mellitus

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator PD Dr. med. Ulrich Rother

Study Record Dates

First Submitted

December 12, 2017

First Posted

December 27, 2017

Study Start

May 1, 2018

Primary Completion

February 1, 2019

Study Completion

March 1, 2019

Last Updated

May 8, 2020

Record last verified: 2020-05

Locations